|
Name |
Decaturin E
|
Molecular Formula | C30H37NO4 | |
IUPAC Name* |
(2S,4aS,4bR,8S,8aR,10aR)-2-hydroxy-1,1,4a,7,8a-pentamethyl-6'-pyridin-3-ylspiro[2,3,4,4b,5,9,10,10a-octahydrophenanthrene-8,2'-3H-furo[3,2-c]pyran]-4'-one
|
|
SMILES |
CC1=CC[C@@H]2[C@]3(CC[C@@H](C([C@@H]3CC[C@]2([C@]14CC5=C(O4)C=C(OC5=O)C6=CN=CC=C6)C)(C)C)O)C
|
|
InChI |
InChI=1S/C30H37NO4/c1-18-8-9-24-28(4)12-11-25(32)27(2,3)23(28)10-13-29(24,5)30(18)16-20-22(35-30)15-21(34-26(20)33)19-7-6-14-31-17-19/h6-8,14-15,17,23-25,32H,9-13,16H2,1-5H3/t23-,24+,25-,28-,29+,30-/m0/s1
|
|
InChIKey |
KDGKESZIIPJZDE-NJPSTFMDSA-N
|
|
Synonyms |
Decaturin E; CHEMBL4761082; J3.516.334D
|
|
CAS | NA | |
PubChem CID | 132562212 | |
ChEMBL ID | CHEMBL4761082 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 475.6 | ALogp: | 5.1 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 68.6 | Aromatic Rings: | 6 |
Heavy Atoms: | 35 | QED Weighted: | 0.511 |
Caco-2 Permeability: | -4.922 | MDCK Permeability: | 0.00003090 |
Pgp-inhibitor: | 0.984 | Pgp-substrate: | 0.026 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.863 |
30% Bioavailability (F30%): | 0.986 |
Blood-Brain-Barrier Penetration (BBB): | 0.355 | Plasma Protein Binding (PPB): | 94.59% |
Volume Distribution (VD): | 2.435 | Fu: | 4.91% |
CYP1A2-inhibitor: | 0.183 | CYP1A2-substrate: | 0.399 |
CYP2C19-inhibitor: | 0.42 | CYP2C19-substrate: | 0.762 |
CYP2C9-inhibitor: | 0.831 | CYP2C9-substrate: | 0.313 |
CYP2D6-inhibitor: | 0.045 | CYP2D6-substrate: | 0.62 |
CYP3A4-inhibitor: | 0.915 | CYP3A4-substrate: | 0.416 |
Clearance (CL): | 8.425 | Half-life (T1/2): | 0.201 |
hERG Blockers: | 0.673 | Human Hepatotoxicity (H-HT): | 0.431 |
Drug-inuced Liver Injury (DILI): | 0.336 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.453 | Maximum Recommended Daily Dose: | 0.949 |
Skin Sensitization: | 0.258 | Carcinogencity: | 0.025 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.972 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003423 | 0.867 | D02STN | 0.341 | ||||
ENC002118 | 0.798 | D06CNP | 0.321 | ||||
ENC002412 | 0.709 | D04GJN | 0.248 | ||||
ENC002102 | 0.629 | D0L2LS | 0.244 | ||||
ENC005020 | 0.597 | D08QKJ | 0.239 | ||||
ENC002192 | 0.582 | D0N0RU | 0.235 | ||||
ENC002080 | 0.578 | D09IPV | 0.234 | ||||
ENC002044 | 0.511 | D0Q6NZ | 0.233 | ||||
ENC003611 | 0.511 | D0U3GL | 0.233 | ||||
ENC002410 | 0.507 | D0Z1XD | 0.233 |